Genscript Biotech (SEHK:1548) Valuation Check After Recent Share Price Pullback

Recent price moves and business snapshot Genscript Biotech (SEHK:1548) has seen the stock slip about 0.5% on the day and roughly 5.6% over the past week, while posting a gain of around 13% over the ...
Business Wire

Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing

SAN FRANCISCO--(BUSINESS WIRE)--Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation ...
MarketWatch

Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps Up

The MarketWatch News Department was not involved in the creation of this content. PISCATAWAY, N.J., Nov. 21, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D ...
Nasdaq

The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development

LONDON, Nov. 21, 2024 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of its GenScript Biotech ...
PR Newswire

GenScript Sets New Benchmark for Responsible Biotech Leadership with 2025 ESG Report

At a time when biotech is increasingly central to global health, and climate resilience, GenScript's ESG Report demonstrates how the company is embedding sustainability, governance, and societal ...
Benzinga.com

GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy

In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...
Benzinga.com

Will Genscript Cash Out Of Legend Biotech In The Face Of Fat Profit Temptation?

Analysts expect annual sales of Carvykti, Legend Biotech’s core cancer therapy, to peak at $7.3 billion With about $2 billion in cash reserves, Genscript isn’t under pressure to sell its 48% holding ...
FiercePharma

Amid geopolitical tensions, Legend sheds GenScript as its majority shareholder

After a financial maneuver by Legend Biotech, GenScript Biotech no longer considers itself the cell therapy biotech’s majority shareholder. (pengtianli/iStock/Getty ...
NJBIZ

GenScript Biotech expands China production facility

GenScript Biotech Corp. has expanded its research capabilities overseas with a new life sciences facility in China, the Piscataway-headquartered company announced May 18. Located in the city of ...
AOL

US lawmakers ask FBI for briefing on GenScript Biotech's links to China

(Reuters) -The U.S. House of Representatives committee on China has asked the FBI and the intelligence community for a briefing on GenScript Biotechnology Co and three subsidiaries to determine if the ...
Seeking Alpha

GenScript, GenScript ProBio, and Legend Biotech Will Attend the 42nd JPM Healthcare Conference, Advancing Innovation and Development in the Healthcare Sector

NANJING, China, Jan. 4, 2024 /PRNewswire/ -- GenScript Biotech, a global leader in life science research and manufacturing services, along with its subsidiaries GenScript ProBio and Legend Biotech ...
Seeking Alpha

Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps Up

PISCATAWAY, N.J., Nov. 21, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the GenScript Biotech Global Forum ...